Références
Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29.
Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/.
Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. NEJM 2014;371:1039–49.
Conroy T, Desseigne F, Ychou M, et al. Folfirinox vs gemcitabine for metastatic pancreatic cancer. NEJM 2011;364:1817–25.
Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. NEJM 2013;369:1691–703.
Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26:v56–v68.
Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005;33:223–31.
Paiella S, Butturini G, Frigerio I, et al. Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study. Dig Surg 2015;32:90–7.
Tasu JP, Vesselle G, Herpe G, et al. Irreversible electroporation for locally advanced pancreatic cancer. Diagn Interv Imaging 2016;97:1297–304.
Vogel A, Rombots, De Rooijet T, et al. Multimodality treatment of locally advanced pancreatic cancer, including Folfirinox chemotherapy, surgical exploration and irreversible electroporation: prospective series of 132 consecutive patients. UEGW Journal 2016,4:A130.
de Wilde RF, Besselink MG, van der Tweel I, et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospitalcmortality. Br J Surg 2012;99:404–10.
Van Hilst J, Walma MS, Vogel JA, et al. Nationwide multidisciplinary online expert panel for pancreatic cancer: initial results. UEGW Journal 2016,4:A131.
TNCD: http://www.tncd.org.
Stöß C, Nitsche U, Stecher L, et al. Primary tumor resection in metastasized colorectal cancer — A meta-analysis. UEGW Journal 2016,4:A471.
Ngamruengphong S, Kamal A, Hajiyeva G, et al. Prevalence of lymph node metastasis and long term survival of T1 rectal carcinoid tumors: an analysis of surveillance, epidemiology, and end results (SEER) database. UEGW Journal 2016,4:A107.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Lecomte, T., Vaillant, E. Actualités en cancérologie digestive à l’UEGW 2016. Acta Endosc 47, 36–38 (2017). https://doi.org/10.1007/s10190-017-0582-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-017-0582-x